コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 survival status (alive, non-maternal death, maternal death).
2 ernal deaths in 2023 (approximately 24.0% of maternal deaths).
3 ecause of decreases in fertility and risk of maternal death.
4 vert heart failure, arrhythmias, and rarely, maternal death.
5 sive disorders - and is the leading cause of maternal death.
6 fusions, and ultimately increase the risk of maternal death.
7 h were important contributing causes of late maternal death.
8 , and 51% aged 10 to 17 years at the time of maternal death.
9 chain of events that can potentially end in maternal death.
10 MAIN OUTCOME(S) AND MEASURES: Maternal death.
11 re unit (ICU), perinatal or fetal death, and maternal death.
12 unts) and ages of new orphans at the time of maternal death.
13 ne of eclampsia, emergency hysterectomy, and maternal death.
14 There was 1 maternal death.
15 elivery-related fistula recurrences, and one maternal death.
16 requiring intensive care unit admission, and maternal death.
17 ould result in ectopic pregnancy and lead to maternal death.
18 nal, fetal, and neonatal outcomes, including maternal death.
19 dditional child deaths and 56 700 additional maternal deaths.
20 account for approximately 60% of additional maternal deaths.
21 acility births, and perinatal, neonatal, and maternal deaths.
22 tics, methodological features, and causes of maternal deaths.
23 ded wide regional variation in the causes of maternal deaths.
24 w to determine the distribution of causes of maternal deaths.
25 There were no maternal deaths.
26 100% in children, 91% in adults, and 78% in maternal deaths.
27 pregnancy-related sepsis accounts for 11% of maternal deaths.
28 e many causes and frequent underreporting of maternal deaths.
29 allow countries to accelerate reductions in maternal deaths.
30 n Bangladesh, including 163 (95% CI, 57-395) maternal deaths.
31 regnancy-related deaths, including 1891 late maternal deaths.
32 587 jaundice-associated deaths, including 25 maternal deaths.
33 (BP) is a significant contributing factor to maternal deaths.
34 sure is a significant contributing factor to maternal deaths.
35 reverse the national trend in comprehensive maternal deaths.
36 not differ between groups, and there were no maternal deaths.
37 rdiovascular disease as the leading cause of maternal deaths.
38 from suicide ranged from below 1% to 26% of maternal deaths.
39 preferentially use InterVA-4 when recording maternal deaths.
40 ministered the WHO 2012 verbal autopsy after maternal deaths.
41 dditional child deaths and 12 200 additional maternal deaths.
42 ecessary to substantially reduce preventable maternal deaths.
43 sthesia-attributed deaths as a proportion of maternal deaths.
44 .4), and sepsis 10.7% (261 000, 5.9-18.6) of maternal deaths.
45 ncluding tuberculosis now account for 28% of maternal deaths.
46 saved, including stillbirths, neonatal, and maternal deaths.
47 .82 million [0.60-0.93 million]), and 54% of maternal deaths (0.16 million [0.14-0.17 million]) per y
48 during and 198 993 before the pandemic) and maternal death (1.37 [1.22-1.53; I(2)=0%, two studies [b
49 4 085 sisters of the survey respondents (593 maternal deaths/100 000 live births per year; 95% confid
50 io 2.4, 95% confidence interval 1.3 to 4.4), maternal death (14.1, 4.1 to 48.0), maternal admission t
52 on in this refugee setting, and neonatal and maternal deaths, 2 important components of reproductive
53 e-delivered interventions could avert 22% of maternal deaths, 23% of neonatal deaths, and 14% of stil
54 ary outcome occurred in 4067 women, with 998 maternal deaths, 2692 eclampsia cases, and 681 hysterect
55 there would be an estimated 28% decrease in maternal deaths, 28% decrease in neonatal deaths, and 22
57 ccounted for 2.8% (2.4-3.4, I(2)=75%) of all maternal deaths, 3.5% (2.9-4.3, I(2)=79%) of direct mate
58 e-delivered interventions could avert 41% of maternal deaths, 39% of neonatal deaths, and 26% of stil
59 to reduce the yearly toll of half a million maternal deaths, 4 million neonatal deaths, and 6 millio
60 2,040 (uncertainty interval 127,937-407,134) maternal deaths (44% reduction), so without contraceptiv
62 [95% CI 1.22-12.83], p=0.022; adjusted OR of maternal death: 5.65 [1.54-20.69], p=0.0090) and the thi
63 including "abortion"; (4) enumerated >/=100 maternal deaths; (5) a quantitative research study; (6)
64 acilities could prevent an estimated 113,000 maternal deaths, 531,000 stillbirths, and 1.325 million
65 e-delivered interventions would avert 67% of maternal deaths, 64% of neonatal deaths, and 65% of stil
66 ely achieve 90% coverage would avert 149 000 maternal deaths, 849 000 stillbirths, 1 498 000 neonatal
69 geographical region, and was associated with maternal death (adjusted odds ratio 2.27, 95% CI 1.62-3.
70 f membranes, and postpartum fever as well as maternal death (adjusted relative risk [aRR], 11.19; 95%
73 agnitude, causes, and preventable factors of maternal deaths among Afghan refugees may yield valuable
74 survey data) to calculate the proportion of maternal deaths among deaths of females of reproductive
76 Despite being one of the leading causes of maternal death and a major contributor of maternal and p
78 bidity and mortality index (MMMI), all-cause maternal death and COVID-19-related hospitalization, whi
79 c and Newborn Care developed by the Averting Maternal Death and Disability programme at Columbia Univ
80 y outcomes were all-cause and cause-specific maternal death and late maternal death (ie, deaths occur
81 ation of pregnancy and is a leading cause of maternal death and major contributor to maternal and per
82 ies and strategies can assist in controlling maternal death and major morbidity secondary to anesthes
83 ologies and strategies can assist in keeping maternal death and major morbidity vanishingly rare.
84 ka Native birthing individuals and causes of maternal death and morbidity and describes a stepwise mu
86 two underappreciated pathways linking early maternal death and offspring fitness that are distinct f
87 nal infection and sepsis are major causes of maternal death and severe illness worldwide, particularl
88 policy would prevent more than 0.11 million maternal deaths and 1.05 million under-5 deaths, avert U
89 with low CDRs could avert as many as 163 513 maternal deaths and 803 129 neonatal deaths annually.
90 le progress has been made towards halving of maternal deaths and deaths of children aged 1-59 months,
94 in poorer quintiles, but would prevent more maternal deaths and private expenditure in wealthier qui
95 analytical methods to generate estimates of maternal deaths and the MMR for each year between 1980 a
97 children aged <5 years [under-5 deaths] and maternal deaths) and private expenditure averted using t
98 al near-miss events and maternal deaths] and maternal death), and neonatal outcomes of interest (stil
100 tly a leading cause of non-pregnancy-related maternal death, and maternal death remains the most comm
102 al mortality, the key causes contributing to maternal death, and timing of maternal death with respec
104 ates to take into account under-reporting of maternal deaths, and deaths during pregnancy from non-ma
106 a composite of maternal near-miss events and maternal deaths] and maternal death), and neonatal outco
114 ccount for the majority of pregnancy-induced maternal deaths, as well as having substantial long-term
120 nal mortality estimation method, to estimate maternal deaths averted by contraceptive use in 172 coun
121 patial memory was negatively correlated with maternal death (beta = -0.55, P = 0.019), and attention
123 About 73% (1 771 000 of 2 443 000) of all maternal deaths between 2003 and 2009 were due to direct
124 and postnatal women is an important cause of maternal death, but evidence to guide suicide prevention
125 n developing countries has cut the number of maternal deaths by 40% over the past 20 years, merely by
131 , and subregional estimates of the causes of maternal death during 2003-09, with a novel method, upda
134 ID-19 pandemic, there were increased odds of maternal death during delivery hospitalization, cardiova
135 in sub-Saharan Africa over the last decade, maternal deaths during pregnancy and in childbirth remai
136 days) neonatal death, congenital anomaly, or maternal death (during pregnancy or discharge postpartum
139 regnancy causing intensive care admission or maternal death experienced a stillbirth or neonatal deat
140 baboons, and blue monkeys), such that early maternal death experienced in one generation leads to re
141 al episodes, with suicide a leading cause of maternal death, few studies are available to guide the m
142 th a hypertensive disorder of pregnancy, and maternal death from a hypertensive disorder of pregnancy
143 Oct 1, 2015, for studies reporting risks of maternal death from anaesthesia in low-income and middle
146 del by considering the key events leading to maternal death from post-partum haemorrhage or sepsis af
148 delivery rate and maternal mortality ratios (maternal death from pregnancy related causes during preg
149 r 7065 site-years and estimate the number of maternal deaths from all causes in 188 countries between
154 ion of misoprostol and antibiotics to reduce maternal deaths from post-partum haemorrhage and sepsis
155 With the model we estimated that of 2860 maternal deaths from post-partum haemorrhage or sepsis p
156 were conducted to estimate the proportion of maternal deaths from suicide and the ratio of maternal t
161 ematic review of reports about the timing of maternal death, identifying 142 sources to use in our an
162 e and cause-specific maternal death and late maternal death (ie, deaths occurring >42 days and up to
163 For countries reporting at least one late maternal death (ie, deaths that occur more than 42 days
164 l deaths, 3.5% (2.9-4.3, I(2)=79%) of direct maternal deaths (ie, those that resulted from obstetric
169 ge of weaning, and offspring that experience maternal death in early life can suffer substantial redu
173 lmonary thromboembolism is the main cause of maternal death in the UK and current trends show an incr
174 Sepsis is now the leading direct cause of maternal death in the United Kingdom, and Streptococcus
183 bserved national estimates for comprehensive maternal deaths in 2021 were the highest in Brazil in th
184 nce rate during this period prevented 77 400 maternal deaths in 2023 (approximately 24.0% of maternal
185 ns of all births, stillbirths, neonatal, and maternal deaths in a health facility would substantially
186 ts of the COVID-19 pandemic on comprehensive maternal deaths in Brazil have not been fully explored.
190 access indicates opportunities for reducing maternal deaths in refugee women and their children.
191 ; 95% CI 25.58-39.92) of 255 health facility maternal deaths in the 2013 preintervention survey to 14
194 afe"; (3) specified and enumerated causes of maternal death including "abortion"; (4) enumerated >/=1
195 e ratio of stillbirth and neonatal deaths to maternal deaths increased from less than 10 in phase 1 t
196 nd southeast Asia between 1990 and 2013, but maternal deaths increased in much of sub-Saharan Africa
197 We recorded similar patterns for all other maternal death indicators, including the maternal mortal
198 outcome was a composite of infection-related maternal death, infection-related near-miss event (event
199 wer risk of a composite of infection-related maternal death, infection-related near-miss event, or se
200 pulmonary embolism, postpartum haemorrhage, maternal death, intensive care unit admission, lower bir
204 as 100,000 deaths annually (about two in ten maternal deaths), mainly in poor countries, where aborti
206 e shown some progress since 1990 in reducing maternal deaths, maternal mortality ratios in sub-Sahara
207 mortality index to severe maternal outcome (maternal death/maternal near miss + maternal death) was
208 progress has been made globally in reducing maternal deaths, measurement remains challenging given t
209 estimates of maternal mortality ratios using maternal deaths (MMR) and comprehensive maternal deaths
210 sing maternal deaths (MMR) and comprehensive maternal deaths (MMRc) in the years 2020 and 2021 based
211 lth policies and programmes aiming to reduce maternal deaths need reliable and valid information.
213 Indonesia, revealed that about 32-34% of the maternal deaths occurred among women from the poorest qu
215 paucity of data on maternal suicide and late maternal deaths occurring beyond 42 days postpartum, add
217 tandard definitions of pregnancy-related and maternal deaths only include deaths that occur within 42
220 change in the rates of eclampsia, stroke, or maternal death or intensive care admission with a hypert
223 e and developmental outcomes, mode of birth, maternal death or severe morbidity, maternal quality of
224 were followed until miscarriage, stillbirth, maternal death, or live birth of one or more infants, wh
225 outcome" (composite of severe hypertension, maternal death, or maternal morbidity; superiority hypot
226 , on a composite outcome of perinatal death, maternal death, or maternal severe complications within
228 ed the maternal mortality ratio--the risk of maternal death per 100,000 livebirths--by about 26% in l
229 n (density) were compared with the number of maternal deaths per 100 000 live births (maternal mortal
231 able Development Goal target of less than 70 maternal deaths per 100 000 livebirths by 2030, with no
232 o 260 [uncertainty 100-410] vs 190 [120-260] maternal deaths per 100 000 livebirths for all 144 count
234 th an increase in maternal mortality of 36.9 maternal deaths per 100,000 live births (95% CI 1.9-72.0
235 lted in an average estimated increase of 7.5 maternal deaths per 100,000 live births (95% confidence
236 ternal mortality ratio (MMR) to less than 70 maternal deaths per 100,000 live births by 2030, with no
238 nable Development Goal (SDG) of less than 70 maternal deaths per 100,000 livebirths globally by 2030.
239 the maternal mortality ratio (MMR; number of maternal deaths per 100,000 livebirths) between 1990 and
240 aths per month, and an 8.3-38.6% increase in maternal deaths per month, across the 118 countries.
243 Africa, we estimated that of 182 000 of such maternal deaths per year, these three packages could pre
249 es, were primarily linked to prematurity and maternal death rather than maternal cancer or its treatm
250 ess reducing maternal mortality, HIV-related maternal deaths remain high, accounting, for example, fo
251 of non-pregnancy-related maternal death, and maternal death remains the most common cause of fetal de
253 l standardized mortality ratio estimates for maternal deaths (SMR) and comprehensive maternal deaths
256 g the COVID-19 pandemic, with an increase in maternal deaths, stillbirth, ruptured ectopic pregnancie
258 ent baseline levels were all found to reduce maternal deaths, stillbirths, and neonatal deaths by 202
259 hs associated with acute jaundice, including maternal deaths, stillbirths, and neonatal deaths delive
261 s have established systems for comprehensive maternal death surveillance and confidential review to e
262 based estimates of the global proportions of maternal deaths that are in HIV-infected women range fro
264 e UK, had enhanced methods for studying late maternal deaths, those occurring between 43 and 365 days
266 termination of pregnancy), the ratio of late maternal deaths to maternal deaths up to 42 days ranged
267 time of highest risk, when more than 40% of maternal deaths (total about 290,000) and stillbirths or
269 gets for 2030: avoid two-thirds of child and maternal deaths; two-thirds of tuberculosis, HIV, and ma
270 s and the latter being the foremost cause of maternal death, underscoring the severe impact on matern
271 nancy), the ratio of late maternal deaths to maternal deaths up to 42 days ranged from <0.01 to 0.07.
272 Methods for identifying and classifying maternal deaths up to 42 days were very similar across c
284 successful follow-up in the CLIP trials, 143 maternal deaths were reported (16 deaths in India, 105 i
290 at ascertaining causes and circumstances of maternal death, when compared with physician review.
291 es were limited to direct/specific causes of maternal death, which are probably subject to less miscl
295 2,900 (uncertainty interval 302,100-394,300) maternal deaths worldwide in 2008, down from 526,300 (44
300 so without contraceptive use, the number of maternal deaths would have been 1.8 times higher than th